Heehyun Won
8 Papers
Heehyun Won is an academic researcher. The author has contributed to research in topics: Warfarin & Adverse Event Reporting System. The author has co-authored 1 publications.
Chat about Author
Papers
Safety of concomitant administration of 23-valent polysaccharide pneumococcal vaccine and influenza vaccine among the elderly.
Heehyun Won,Na-Young Jeong,Nam-Kyong Choi +2 more
TL;DR: Concomitant administration of PPSV-23 and influenza vaccine in the elderly was not associated with a higher risk of most prespecified adverse events (AEs) compared to sequential vaccination, and this study supports the safety of concomitant administration of PPSV-23 and influenza vaccine.
1
Immunization Status of the 23-Valent Pneumococcal Polysaccharide Vaccine among Elderly Aged 65 and Older in South Korea
Jeong Ah Kim,Heehyun Won,Na-Young Jeong,Nam-Kyong Choi +3 more
TL;DR: Although the cumulative PPSV23 vaccination coverage rates for people aged 65 years and older have been steadily increasing, instances of non-adherence to the minimum intervals between pneumococcal vaccines have been observed and education and promotion programs aimed at healthcare providers and the general public are needed to increase awareness.
1
Statistical Methodologies for Detecting Drug-Drug Interaction Using Spontaneous Reporting System
Heehyun Won,Haerin Cho,Hyunyoung Choi,Nam-Kyong Choi +3 more
TL;DR: Statistical methodologies for DDI signal detection using spontaneous reporting system are reviewed. Various models are described and their advantages and disadvantages discussed.
1
Detecting Drug Interaction Signal of Concomitant Use of Warfarin and Statins Using Korea Adverse Event Reporting System Database
TL;DR: In this article , the authors detect signals of adverse events (AEs) for DDI after concomitant use of warfarin and statins using Korea adverse events reporting system (KAERS) database from January 2016 to December 2020.
1
Effectiveness of COVID-19 vaccines against severe outcomes in cancer patients: Real-world evidence from self-controlled risk interval and retrospective cohort studies
Hui-Eon Lee,Na-Young Jeong,Minah Park,Eunsun Lim,Heehyun Won,Chung-Jong Kim,Nam-Kyong Choi +6 more
TL;DR: This study evaluates COVID-19 vaccine effectiveness in cancer patients using self-controlled risk interval and retrospective cohort designs, finding vaccines significantly reduce severe outcomes risk, but not breakthrough infection risk, in vaccinated cancer patients compared to unvaccinated counterparts.